Health & Fitness

Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against it. Instead of attacking cancer cells head-on, the experimental immunotherapy targets macrophages—immune cells that tumors hijack to shield themselves from attack. By eliminating or reprogramming these “bodyguards,” the treatment cracks open the tumor’s protective barrier and allows the immune system to flood in and destroy the cancer.

from Top Health News -- ScienceDaily https://ift.tt/8C6tQJ4

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc lowered cholesterol, blood fats, and artery-clogging plaques while calming inflammation linked to heart attacks and strokes. Notably, these benefits appeared even without weight loss, suggesting the drug could help lean people at risk of heart disease.

from Top Health News -- ScienceDaily https://ift.tt/YvUc79b

Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor can be seen. IDH-mutant glioma, long treated by removing visible tumor tissue, actually starts when normal-looking brain cells quietly acquire a cancer-linked mutation and spread through the brain’s cortex. Using advanced genetic mapping and animal models, researchers traced the cancer’s true origin to glial progenitor cells that appear healthy at first.

from Top Health News -- ScienceDaily https://ift.tt/37dTEOI

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these drugs than after diet and exercise alone. Improvements in heart health and diabetes risk also tend to reverse within a few years. The results suggest long-term success may require more than medication alone.

from Top Health News -- ScienceDaily https://ift.tt/MyWfpq5